NYMC Faculty Publications
Risk Factors for Optic Disc Hemorrhage in the Low-Pressure Glaucoma Treatment Study
Author Type(s)
Faculty
DOI
10.1016/j.ajo.2014.02.009
Journal Title
American Journal of Ophthalmology
First Page
945
Last Page
952
Document Type
Article
Publication Date
5-1-2014
Department
Ophthalmology
Keywords
Antihypertensive Agents, Blood Pressure, Brimonidine Tartrate, Double-Blind Method, Female, Follow-Up Studies, Humans, Intraocular Pressure, Low Tension Glaucoma, Male, Middle Aged, Optic Disk, Proportional Hazards Models, Quinoxalines, Retinal Hemorrhage, Risk Factors, Timolol
Disciplines
Medicine and Health Sciences
Abstract
PURPOSE: To investigate risk factors for disc hemorrhage detection in the Low-Pressure Glaucoma Treatment Study.
DESIGN: Cohort of a randomized, double-masked, multicenter clinical trial.
METHODS: Low-Pressure Glaucoma Treatment Study patients with at least 16 months of follow-up were included. Exclusion criteria included untreated intraocular pressure (IOP) of more than 21 mm Hg, visual field mean deviation worse than -16 dB, or contraindications to study medications. Patients were randomized to topical treatment with timolol 0.5% or brimonidine 0.2%. Stereophotographs were reviewed independently by 2 masked graders searching for disc hemorrhages. The main outcomes investigated were the detection of disc hemorrhage at any time during follow-up and their recurrence. Ocular and systemic risk factors for disc hemorrhage detection were analyzed using the Cox proportional hazards model and were tested further for independence in a multivariate model.
RESULTS: Two hundred fifty-three eyes of 127 subjects (mean age, 64.7 ± 10.9 years; women, 58%; European ancestry, 71%) followed up for an average ± standard deviation of 40.6 ± 12 months were included. In the multivariate analysis, history of migraine (hazard ratio [HR], 5.737; P = .012), narrower neuroretinal rim width at baseline (HR, 2.91; P = .048), use of systemic β-blockers (HR, 5.585; P = .036), low mean systolic blood pressure (HR, 1.06; P = .02), and low mean arterial ocular perfusion pressure during follow-up (HR, 1.172; P = .007) were significant and independent risk factors for disc hemorrhage detection. Treatment randomization was not associated with either the occurrence or recurrence of disc hemorrhages.
CONCLUSIONS: In this cohort of Low-Pressure Glaucoma Treatment Study patients, migraine, baseline narrower neuroretinal rim width, low systolic blood pressure and mean arterial ocular perfusion pressure, and use of systemic β-blockers were risk factors for disc hemorrhage detection. Randomization assignment did not influence the frequency of disc hemorrhage detection.
Recommended Citation
Furlanetto, R. L., De Moraes, C., Teng, C. C., Liebmann, J. M., Greenfield, D. S., Gardiner, S. K., Ritch, R., & Krupin, T. (2014). Risk Factors for Optic Disc Hemorrhage in the Low-Pressure Glaucoma Treatment Study. American Journal of Ophthalmology, 157 (5), 945-952. https://doi.org/10.1016/j.ajo.2014.02.009
